This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Terumo Kabushiki Kaisha. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Takanobu Ishizuka: Innovator in Tumor Treatment Methods
Introduction
Takanobu Ishizuka is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of tumor cells. With a total of 2 patents, his work focuses on innovative methods that aim to enhance patient care and treatment efficacy.
Latest Patents
Ishizuka's latest patents include a groundbreaking treatment method designed to reduce the burden on patients while effectively killing tumor cells. This method involves administering an antibody-photosensitive substance into a vein, followed by the insertion of an endoscope to target the tumor. The procedure utilizes optical fibers to irradiate the tumor and its vicinity with near-infrared rays, enhancing the effectiveness of the treatment. Another patent outlines a similar approach, where a catheter is inserted into the main artery of the organ containing the tumor, allowing for precise delivery of the treatment while minimizing blood interference.
Career Highlights
Takanobu Ishizuka is currently associated with Terumo Kabushiki Kaisha, a leading company in the medical technology sector. His work at Terumo has been instrumental in advancing treatment methodologies that prioritize patient comfort and treatment success.
Collaborations
Ishizuka collaborates with notable colleagues, including Keiko Otsu and Yuji Onimura. Their combined expertise contributes to the innovative solutions being developed in the field of tumor treatment.
Conclusion
Takanobu Ishizuka's contributions to medical technology, particularly in tumor treatment methods, highlight his commitment to improving patient outcomes. His innovative approaches and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
